# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA933672 | B | Inhibition of human cathepsin L | Homo sapiens | 10 | ALA1145569 | single protein format | Scientific Literature | |
2. | ALA5227033 | F | Antiviral activity against SARS-CoV infected in HEK293T cells assessed as reduction in viral replication incubated for 7 hrs by luciferase assay | Severe acute respiratory syndrome-related coronavirus | 1 | ALA5226291 | organism-based format | Scientific Literature | |
3. | ALA5227034 | F | Antiviral activity against Ebolavirus infected in HEK293T cells assessed as reduction in viral replication incubated for 7 hrs by luciferase assay | Ebolavirus | 1 | ALA5226291 | organism-based format | Scientific Literature | |
4. | ALA5227035 | B | Inhibition of human liver Cathepsin L using Z-Phe-Arg-AMC as substrate incubated for 30 mins by fluorometric assay | Homo sapiens | 2 | ALA5226291 | tissue-based format | Scientific Literature | |
5. | ALA5230438 | B | Inhibition of human recombinant Cathepsin L assessed as Kinact using Z-FR-AMC as substrate incubated for 30 mins by fluorometric assay | Homo sapiens | 8 | ALA5230087 | single protein format | Scientific Literature | |
6. | ALA5230445 | F | Antiviral activity against pseudovirus SARS-CoV spike protein infected in HeLa cells over expressing ACE2 assessed as inhibition on pseudovirus infection incubated for 52 hrs by luminescence based microplate reader analysis | Severe acute respiratory syndrome coronavirus 2 | 6 | ALA5230087 | cell-based format | Scientific Literature | |
7. | ALA5230460 | T | Toxicity in C57 mouse at 10 mg/kg, po administered twice daily | Mus musculus | 1 | ALA5230087 | organism-based format | Scientific Literature | |
8. | ALA5230461 | F | Antiviral activity against Ebola virus trVLP assessed as reduction in RNA synthesis at 1 uM by qPCR analysis | Ebolavirus | 1 | ALA5230087 | organism-based format | Scientific Literature |